Clinical trial Recruiting at 1 site Observational Ages 18 to 80

Predicting brain swelling after stroke treatment

Official title: Early Identification of Malignant Brain Edema in laRge Artery oCclusive Stroke After Endovascular Therapy (EMBRACE Study)

Run by Zhejiang Provincial People's Hospital · NCT06451887 · Data updated 2026-11-12

This study is testing a new way to predict which stroke patients are at risk for dangerous brain swelling after a specific treatment to help doctors make better decisions for their care.

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment1950 (estimated)
SponsorZhejiang Provincial People's Hospital
Academic / other
Locations1 site (Hangzhou, Zhejiang)
StatusRecruiting
StartedApril 1, 2024
Main results expectedMarch 2027
Study endsJune 2027
Registry record updatedJune 11, 2024
Trial IDNCT06451887 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults over 18 years old who have experienced an ischemic stroke and are undergoing endovascular thrombectomy within 24 hours of symptom onset.

Probably not a fit

Patients with posterior circulation occlusion or those with severe comorbidities that limit their expected survival may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to design and validate a predictive model for malignant brain edema (MBE) following endovascular thrombectomy (EVT) in patients with acute large vessel occlusion stroke. By identifying high-risk patients for MBE, clinicians can make informed decisions regarding triage and early interventions, potentially improving patient outcomes. The study will analyze various predictive factors, including clinical and radiological indicators, to enhance the accuracy of early predictions for MBE. The ultimate goal is to reduce morbidity and mortality associated with this severe complication of stroke treatment.

Why it matters

Potential benefit: If successful, this study could lead to improved patient outcomes by enabling timely interventions for those at high risk of malignant brain edema.

How similar studies have gone: Previous studies have shown promise in identifying predictive factors for malignant brain edema, suggesting that this approach may yield valuable insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* (1)Age \> 18 years old; (2)Onset of stroke to hospital admission \< 24 hours; (3)Admission with a head CT scan ruling out hemorrhage; (4)Patients undergoing CT perfusion scan before treatment; (5)Confirmation of internal carotid artery (ICA) or middle cerebral artery (MCA) occlusion or tandem occlusion by Digital Subtraction Angiography (DSA) and subsequent EVT; (6)complete 3-months follow-up.

Exclusion Criteria:

* (1)Poor quality of preoperative CT perfusion imaging; (2)Posterior circulation occlusion or isolated anterior cerebral artery occlusion; (3)Presence of other severe diseases such as malignant tumors, severe organ failure, or other life-threatening conditions with an expected survival period of less than 90 days; (4)Incomplete imaging and clinical data.

Where it's running

  • Zhejiang Provincial People's Hospital
    Hangzhou, Zhejiang, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals

    This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.

    Recruiting at 2 sites Hospital Universitari Vall d'Hebron Research Institute · Leuven and 6 other locations · NCT07924371

  • Remote ischemic conditioning for post-stroke insomnia

    A 136-person, randomized study will test whether a non-invasive arm-cuff procedure done twice daily for 90 days can improve sleep after a first ischemic stroke in adults 18–80.

    Recruiting Sichuan Academy of Medical Sciences · Chengdu, Sichuan · NCT07874594

  • Ear-based nerve stimulation to help sleep after a stroke

    A device that delivers vagal nerve stimulation through the ear is tested to see if it helps stroke patients in rehab sleep better.

    Recruiting Casa Colina Hospital and Centers for Healthcare · Pomona, California · NCT07858656

  • Theta Burst Stimulation to Help Stroke Recovery (Upper and Lower Limbs)

    This trial tests whether applying theta burst stimulation to the motor cortex, in combination with standard rehabilitation, helps people over 45 who recently had a first ischemic stroke recover arm and leg movement.

    Recruiting Ankara Etlik City Hospital · Ankara, Yenimahalle · NCT07834333

  • Preventing another ischemic stroke with a smart bracelet and app

    This study tests whether a digital prevention program using a wearable and a mobile app can help people who recently had an ischemic stroke reduce the chance of another stroke and improve risk-factor control.

    Recruiting Affiliated Hospital of Nantong University · Nantong, Jiangsu · NCT07825311

  • Photon-counting CT to check intracranial stents

    This study tests whether ultra-high-resolution photon-counting CT can reliably visualize intracranial stents and detect in-stent restenosis during follow-up of patients with prior stents.

    Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07769814

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.